Skip to content

Efficacy of electroacupuncture for dry eye and its influence on ocular surface function: a clinical study

Efficacy of electroacupuncture for dry eye and its influence on ocular surface function: a clinical study

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000040909
Enrollment
Unknown
Registered
2020-12-15
Start date
2020-12-04
Completion date
Unknown
Last updated
2021-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dry Eye

Interventions

Experimental group:Electroacupuncture

Sponsors

Shanghai Research Institute of Acupuncture and Meridian
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1.Meet the diagnostic criteria for DE; 2.Patients with mild to moderate DE; 3.Aged >= 18 years old and <= 65 years old, regardless of gender; 4.Understand and agree to participate in this study and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1.Complicated with other eye diseases (such as blepharospasm, conjunctivochalasis, strabismus, amblyopia, glaucoma, cataract, fundus diseases, etc.); 2.Recently (within 3 months) patients with ocular activity lesions or eye surgery; 3.Recently (within 1 month) patients have received acupuncture treatment or other oral/topical drugs for eye diseases; 4.Pregnant or lactating; 5.Patients with cardiovascular, cerebrovascular, liver, kidney, hematopoietic system and other serious systemic diseases and mental diseases; 6.Patients with Sjogren's syndrome, rheumatoid arthritis, lupus erythematosus, ankylosing spondylitis and other autoimmune diseases; 7.Skin damage, ulcer, infection and scar at acupoints.

Design outcomes

Primary

MeasureTime frame
Ocular Surface Disease Index;Noninvasive Tear Break-up Time;Schirmer I Test;Tear Meniscus Height;Cornea Fluorescein Staining;

Secondary

MeasureTime frame
Corneal Topography;Corneal Sensation;Meibomian Gland Evaluation;The quality of life scale which measures the quality of life for Chinese patients with visual impairment;36-item Short Form Health Survey;Hospital Anxiety and Depression Scale;

Countries

China

Contacts

Public ContactXiaopeng Ma

Shanghai Research Institute of Acupuncture and Meridian

pengpengma@163.com+86 13917140446

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026